Table of Contents
Vitamins and Dietary Supplements in Poland
Euromonitor International
April 2009
List of Contents and Tables
Executive Summary
Increased
Spending on OTC Drugs
New Innovative Products Fuel Demand
Multinationals Dominate Sales
Non-pharmacy Channel Sales Continue To
Increase
Further Growth Expected
Key Trends and Developments
Health and Wellness Trend Increases in Popularity
Self-medication
Increases in Popularity
Lifestyle and Environmental Changes Shape Consumer
Behaviour
Innovations Fuel Growth
Increasing Child-specific Product
Sales
Market Indicators
Table 1 Consumer Expenditure on Health Goods
and Medical Services 2003-2008
Table 2 Life Expectancy at Birth
2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value
2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth
2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of
OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales
of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table
9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10
Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Vitamins & Dietary
Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Re-classifications
Summary 1 OTC healthcare Switches 2005-2007
Definitions
Summary 2 Research Sources
Aflofarm Farmacja Polska Sp
Zoo
Strategic Direction
Key Facts
Summary 3 Aflofarm Farmacja
Polska Sp zoo: Key Facts
Summary 4 Aflofarm Farmacja Polska Sp zoo:
Operational Indicators
Company Background
Production
Summary 5
Aflofarm Farmacja Polska Sp zoo: Production Statistics 2007
Competitive
Positioning
Summary 6 Aflofarm Farmacja Polska Sp zoo: Competitive
Position 2008
Jelfa SA
Strategic Direction
Key Facts
Summary 7
Jelfa SA: Key Facts
Summary 8 Jelfa SA: Operational Indicators
Company
Background
Production
Summary 9 Jelfa SA: Production Statistics
2007
Competitive Positioning
Summary 10 Jelfa SA: Competitive Position
2008
Polpharma SA
Strategic Direction
Key Facts
Summary 11
Polpharma SA: Key Facts
Summary 12 Polpharma SA: Operational
Indicators
Company Background
Production
Summary 13 Polpharma SA:
Production Statistics 2007
Competitive Positioning
Summary 14
Polpharma SA: Competitive Position 2008
Polski Lek SA
Strategic
Direction
Key Facts
Summary 15 Polski Lek SA: Key Facts
Summary 16
Polski Lek SA: Operational Indicators
Company Background
Production
Summary 17 Polski Lek SA: Production Statistics 2007
Competitive Positioning
Summary 18 Polski Lek SA: Competitive Position
2008
Ppf Hasco-lek SA
Strategic Direction
Key Facts
Summary 19
PPF Hasco-Lek SA: Key Facts
Summary 20 PPF Hasco-Lek SA: Operational
Indicators
Company Background
Production
Summary 21 PPF Hasco-Lek
SA: Production Statistics 2007
Competitive Positioning
Summary 22 PPF
Hasco-Lek SA: Competitive Position 2008
Headlines
Trends -
Vitamins
Trends - Dietary Supplements
Competitive Landscape
Prospects
Sector Data
Sector Data
Table 12 Sales of Vitamins and
Dietary Supplements by Subsector: Value 2003-2008
Table 13 Sales of
Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 14 Folic Acid v Other B Vitamins 2004-2008
Table 15 Dietary
Supplements by Positioning 2006-2008
Table 16 Vitamins and Dietary
Supplements Company Shares by Value 2004-2008
Table 17 Vitamins and
Dietary Supplements Brand Shares by Value 2005-2008
Table 18 Vitamins
Brand Shares by Value 2005-2008
Table 19 Dietary Supplements Brand Shares
by Value 2005-2008
Table 20 Forecast Sales of Vitamins and Dietary
Supplements by Subsector: Value 2008-2013
Table 21 Forecast Sales of
Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
| 
View Cart
